Adma Biologics reported $54.76M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Adma Biologics USD 54.76M 544K Jun/2025
Alnylam Pharmaceuticals USD 142.95M 71.91M Jun/2025
Dynavax Technologies USD 14.04M 13.5M Jun/2025
Takeda JPY 384.68B 2.6B Jun/2025